Track BiomX Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BiomX Inc. PHGE · Stock Open BiomX Inc. in new tab

1.85 USD
Add to portfolio
P/E
0.02
EPS
-153.23
P/B
0.54
ROE
-247.34
Beta
1.34
BiomX Inc. logo

BiomX Inc.

🧾 Earnings Recap – Q3 2025

BiomX reported significant advancements in its clinical programs despite regulatory challenges, maintaining confidence in its innovative phage therapy pipeline.

  • Initiated Phase IIb trial for BX004 with first patient dosing, though faced a temporary clinical hold from the FDA related to the nebulizer delivery device.
  • Received positive FDA feedback on BX011’s development for diabetic foot infections, outlining a clear pathway towards a Biologics License Application (BLA).
  • European trials for BX004 continue without interruption, with planned data reporting set for Q1 2026.
  • BX011 targets a critical unmet need in diabetic foot infections, promising substantial commercial potential in a market with no new drugs approved in over 20 years.
  • Company remains optimistic about upcoming discussions with the FDA and the Department of Defense Health Agency as part of its strategic partnerships.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 11, 2026
P/E0.02
EPS-153.23
Book Value3.46
Price to Book0.54
Debt/Equity7.75
% Insiders10.447%
Estimates
Forward P/E-0.03
Forward EPS-60.10

DCF Valuation

Tweak assumptions to recompute fair value for BiomX Inc. (PHGE)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

BiomX Inc. Logo BiomX Inc. Analysis (PHGE)

Israel Health Care Official Website Stock

Is BiomX Inc. a good investment? BiomX Inc. (PHGE) is currently trading at 1.85 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.02. This relatively low multiple may signal that BiomX Inc. is undervalued compared to historical market norms.

Earnings Schedule: BiomX Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -60.10.

Investor FAQ

Does BiomX Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is BiomX Inc.?

BiomX Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -153.23.

Company Profile

Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies. The company develops threat detection technology for defense and security applications, including counter-drone systems, perimeter and border security, wide-area surveillance, and aerial firefighting. It also provides AI-powered prediction, analysis, validation, coordination, and response recommendation and initiation capabilities for defense and critical infrastructure operations. Additionally, the company offers electric motor testing and validation for unmanned and autonomous systems. Its integrated technology portfolio serves counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting applications. The company serves defense, homeland security, and critical infrastructure customers. Tessera Defense and Homeland Security Inc. was formerly known as BiomX Inc. and changed its name to Tessera Defense and Homeland Security Inc. in September 2026. Tessera Defense and Homeland Security Inc. was incorporated in 2015 and is based in Dover, Delaware.

Exchange Ticker
ASE (United States) PHGE
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 26, 2024 1:10
Nov. 25, 2025 1:19
Sept. 9, 2026 1:10
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion